VIDAS? MEASLES IGG 30219

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-07-06 for VIDAS? MEASLES IGG 30219 manufactured by Biomerieux Sa.

Event Text Entries

[48925684] A customer in the (b)(6) notified biom? Rieux of a false positive result with the vidas? Measles igg (reference (b)(4)); a single specimen (specimen (b)(4)) was tested during (b)(6) qc. In pre-distribution testing the measles igg results were negative with trinity biotech, captia, siemens enzygnost, diasorin liaison assays and equivocal with biom? Rieux vidas?. Based on the information provided there was no adverse events, negative patient impact or delay in results.
Patient Sequence No: 1, Text Type: D, B5


[55591033] This report was initially submitted following notification that a customer in the (b)(6) reported an occurrence of a false positive result for (b)(6) specimen (b)(6) in association with the vidas measles igg assay. The expected result was "negative". Biom? Rieux investigation was conducted. The (b)(6) (distribution (b)(6)) report indicates: one-hundred thirty-six (136) participants gave the correct answer negative. Twenty-five (25) participants gave an equivocal answer (24 participants using vidas msg). Eighteen (18) participants gave a positive answer (15 participants using vidas msg). In pre-distribution testing, the measles igg results were negative with trinity biotech, captia, siemens enzygnost, diasorin liaison assays and equivocal with biom? Rieux vidas. Review of complaint history indicates that no other complaint has been registered for vidas msg lot 1004457540 / 160929-0 for external control from (b)(6). Analysis of the manufacturing batch history records showed no anomaly during the control process. The analysis of the control charts for five (5) internal (b)(6) (three negative and two positive) on six (6) vidas? Msg batches showed that all results are in the trend and within specifications or acceptable without change of interpretation. The quality product laboratory tested internal (b)(6) on the retain kit vidas msg 1004457540 / 160929-0; the results were compliant with specifications. There is no evidence to suggest the performance of vidas msg lot 1004457540 / 160929-0 is outside specification.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002769706-2016-00115
MDR Report Key5772824
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-07-06
Date of Report2016-07-01
Date Mfgr Received2016-07-01
Date Added to Maude2016-07-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JONATHAN NONNEMACHER
Manufacturer Street100 RODOLPHE STREET
Manufacturer CityDURHAM NC 27712
Manufacturer CountryUS
Manufacturer Postal27712
Manufacturer Phone9196203396
Manufacturer G1BIOMERIEUX SA
Manufacturer StreetCHEMIN DE L ORME
Manufacturer CityMARCY L ETOILE, RHONE 69280
Manufacturer CountryFR
Manufacturer Postal Code69280
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameVIDAS? MEASLES IGG
Generic NameVIDAS? MEASLES IGG
Product CodeLJB
Date Received2016-07-06
Catalog Number30219
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerBIOMERIEUX SA
Manufacturer AddressCHEMIN DE L ORME MARCY L ETOILE, RHONE 69280 FR 69280


Patients

Patient NumberTreatmentOutcomeDate
10 2016-07-06

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.